April 28th 2024
Nurses must increase the frequency of their assessments for early intervention of patients who undergo treatment for their head and neck cancer, in an effort to truly individualized care.
Equalizing Inequities™ in Multiple Myeloma Care: Shining a Light on Current Barriers and Opportunities for Improved Outcomes
View More
Community Oncology Connections™: Overcoming Barriers to Testing, Trial Access, and Equitable Care in Cancer
View More
Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board
View More
Should Surveillance Schedules Apply to HPV-Associated Oropharyngeal Squamous Cell Carcinomas?
August 16th 2019A new study looked at what methods were used to detect recurrences of human papillomavirus (HPV)-associated oropharyngeal squamous cell carcinoma to see if surveillance guidelines recommended by the National Comprehensive Cancer Center were effective.
Durvalumab Shows Promise in Advanced Head and Neck Cancer
February 20th 2018A phase II trial found that the immune checkpoint inhibitor durvalumab has promising clinical activity and is well tolerated both as monotherapy and in combination with tremelimumab in patients with heavily pretreated recurrent or metastatic head and neck cancer, whose tumors are PD-L1 low or negative.
Adding Nivolumab to Standard First-Line Therapy Feasible in Advanced Head and Neck Cancer
February 20th 2018An early phase trial found that it is feasible to combine nivolumab immunotherapy with radiation therapy and chemotherapy in patients with newly diagnosed local-regionally advanced head and neck cancers.
Reduced RT Feasible in Chemo-Sensitive HPV-Associated Head and Neck Cancer
February 19th 2018Patients with human papillomavirus–associated head and neck cancers who respond well to induction therapy can receive substantially lower doses of radiation and still achieve good safety and efficacy outcomes, according to a new phase II trial.
Emergence of a Novel Staging System for Oropharyngeal Squamous Cell Carcinoma Based on HPV Status
December 15th 2017The staging of oropharyngeal squamous cell carcinoma has undergone key changes in the eighth edition of the American Joint Committee on Cancer Staging Manual, set to take effect January 1, 2018. We describe the revised staging parameters and the rationale in support of the changes.
Pretreatment Cognitive Impairment Is Common in Patients With Head and Neck Cancer
December 1st 2017Results from a study of patients with newly diagnosed head and neck cancer indicate that cognitive screening should be incorporated into pretreatment assessment for patients in order to improve outcomes.
Single Visit to Multidisciplinary Clinic Improved Efficiency of Head and Neck Cancer Care
October 31st 2017Use of a single-day multidisciplinary clinic visit allowed for more efficient and comprehensive cancer care in a group of patients with head and neck cancer, according to the results of a new study.
Unilateral IMRT Is Effective in Palatine Tonsillar Cancer
October 2nd 2017Use of unilateral intensity-modulated radiotherapy reduced acute toxicities and maintained oncologic outcomes compared with bilateral IMRT in patients with lateralized palatine tonsillar cancer, according to the results of a new study.
FDG-PET/CT With Standardized Reporting Reliable Surveillance for HNSCC
September 30th 2017FDG-PET/CT surveillance using a standardized reporting criteria 12 weeks after concurrent chemoradiotherapy was reliable in patients with locoregionally advanced head and neck squamous cell carcinoma, except in patients with late manifesting residual disease, according to the results of the ECLYPS study.